Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: The Vet who wrote (100429)	8/5/2009 8:09:20 PM
From: skinowski	1 Recommendation Respond to of 116555

I am not a wholesale defender of drug companies - Most criticisms aired during this discussion are valid. But they are not evil demons either. They are companies manufacturing products which they aim to market and sell the best way they know - and they do not always know best. I'm no admirer of direct advertisement to patients, like with (as Meta mentioned) the "hard on" pills.

To: The Vet who wrote (100429)	8/5/2009 10:05:15 PM
From: Little Joe	Read Replies (1) \| Respond to of 116555

"TV advertisements don't necessarily make good medicine or good health but they sure create drug company profits...." From which they derive profits to create more drugs. lj

To: The Vet who wrote (100429)	8/6/2009 9:32:31 AM
From: Oblomov	Read Replies (3) \| Respond to of 116555

>>In the US every big pharma company spends more on advertising and lobbying than they do on research... Not true in the case of most pharma companies. Certainly it is true in the case of the generic manufacturers. Branded pharma manufacturers spend more on meeting regulatory requirements (of which over half is spent on Phase 3 trials) than they do on clinical research or marketing. The regulatory agencies should be empowered with ensuring safety only. There have been some failures in this basic function, so it should be the FDA's sole focus. We should let the doctor use third party research to make decisions about efficacy. The result would be more widely available and much cheaper drugs.